Published in Healthcare Finance, Tax and Law Weekly, June 13th, 2007
Tim McCarthy brings to Novexin extensive experience in the biotechnology industry. He has been instrumental in the start up and development of a number of successful biotechnology companies over the past 15 years, including being a founder member of vaccine company Peptide Therapeutics (now Acambis). He was a founder of and is currently Finance Director of biopharmaceutical development company Alizyme....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.